Opinion

Video

Key Takeaways on the Evolving COPD Treatment Landscape

Author(s):

Fernando J. Martinez, MD, MS,Nicola Hanania, MD, MS

The panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.

Video content above is prompted by the following question:

  • What are your key takeaways on the evolving COPD treatment landscape?
Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Discussing New Updates to GOLD 2025 Report, with Gerard Criner, MD
November 29th 2024

Discussing New Updates to GOLD 2025 Report, with Gerard Criner, MD

Tim Smith
Checking in on the Lung Health Cohort Trial
October 29th 2024

Checking in on the Lung Health Cohort Research Study

Kevin Kunzmann
Antonio Anzueto, MD | Credit: UT Health San Antonio
October 14th 2024

The Potential Role of Dupilumab in COPD Management, with Antonio Anzueto, MD

Patrick Campbell
Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD
September 30th 2024

Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD

Kevin Kunzmann
Jessica Bon, MD, MS | Credit: LinkedIn
October 8th 2024

CHEST 2024: Ensifentrine Improves Lung Function, Quality of Life Regardless of COPD Severity

Patrick Campbell
FDA Approves Dupilumab as Add-On Treatment for COPD
September 27th 2024

FDA Approves Dupilumab (Dupixent) for Treatment of COPD

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.